Small molecule metabolites: discovery of biomarkers and therapeutic targets

S Qiu, Y Cai, H Yao, C Lin, Y Xie, S Tang… - Signal Transduction and …, 2023 - nature.com
Metabolic abnormalities lead to the dysfunction of metabolic pathways and metabolite
accumulation or deficiency which is well-recognized hallmarks of diseases. Metabolite …

Lysine crotonylation of SERCA2a correlates to cardiac dysfunction and arrhythmia in Sirt1 cardiac-specific knockout mice

HX Chen, XC Wang, HT Hou, J Wang, Q Yang… - International Journal of …, 2023 - Elsevier
Protein post-translational modifications (PTMs) are important regulators of protein functions
and produce proteome complexity. SIRT1 has NAD+-dependent deacylation of acyl-lysine …

Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure

H Zhang, L Wang, D Yin, Q Zhou, L Lv, Z Dong, Y Shi - BMC genomics, 2022 - Springer
Background The exact mechanism of atrial fibrillation (AF)-induced heart failure (HF)
remains unclear. Proteomics and metabolomics were integrated to in this study, as to …

Cross-sectional gene-smoking interaction analysis in relation to subclinical atherosclerosis-results from the IMPROVE study

B Maitusong, F Laguzzi, RJ Strawbridge… - Circulation: Genomic …, 2023 - Am Heart Assoc
Background: Smoking is associated with carotid intima-media thickness (C-IMT). However,
knowledge about how genetics may influence this association is limited. We aimed to …

[HTML][HTML] Moricizine prevents atrial fibrillation by late sodium current inhibition in atrial myocytes

T Zou, Q Chen, C Chen, G Liu, Y Ling… - Journal of Thoracic …, 2022 - ncbi.nlm.nih.gov
Background Enhanced late sodium current (INaL) is reportedly related to an increased risk
of atrial fibrillation (AF). Moricizine, as a widely used anti-arrhythmia drug for suppressing …

Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction

J Zhou, HT Hou, Y Song, XL Zhou, HX Chen, LL Zhang… - Biomolecules, 2024 - mdpi.com
Myocardial infarction (MI), including ST-segment elevation MI (STEMI) and non-ST-segment
elevation MI (NSTEMI), is still a leading cause of death worldwide. Metabolomics technology …

Metabolomics and Biomarkers for Paroxysmal and Persistent Atrial Fibrillation

LL Zhang, WH Lin, CY Di, HT Hou… - Journal of the …, 2024 - Am Heart Assoc
Background Atrial fibrillation (AF) is the most common type of arrhythmia worldwide and is
associated with serious complications. This study investigated the metabolic biomarkers …

[HTML][HTML] Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation

M Zhao, X Liu, X Bu, Y Li, M Wang, B Zhang, W Sun… - PeerJ, 2022 - peerj.com
Rivaroxaban, an oral factor Xa inhibitor, has been used to treating a series of
thromboembolic disorders in clinical practice. Measurement of the anticoagulant effect of …

Further Advances in Atrial Fibrillation Research: A Metabolomic Perspective

L Arbeloa-Gómez, J Álvarez-Vidal… - Applied Sciences, 2022 - mdpi.com
Atrial fibrillation involves an important type of heart arrhythmia caused by a lack of control in
the electrical signals that arrive in the heart, produce an irregular auricular contraction, and …

Multi-omics approaches in research of cardiovascular diseases

HE Guo-Wei - Scripta Medica, 2022 - aseestant.ceon.rs
Cardiovascular diseases remain number 1 killer world-wide. New technologies, particularly
the novel approaches at genetics, transcriptomics, proteomics and metabolomics levels …